Branding Biotech – Communicating the Brand’s Point of Differentiation

This is a guest post from Brannon Cashion, President of Addison Whitney Health. Do you have a response to Brannin’s post? Respond in the comments section below. The branding process in the biotech sector can be related to the oxymoronic term of “new and improved.” While there is great benefit to being new, and also to […]


Will Brexit Actually Happen?

Following two posts on Brexit and British biotechnology, I would like to provide a perspective that turns everything on its head. It seems increasingly unlikely that Brexit will actually take place. The rationale for this argument has nothing to do with Britons having second thoughts, but is based on economic and legal arguments. Firstly, the […]


Biotechblog